UBS Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Sell |
2,038,919
-104,191
| -5% | -$118K | ﹤0.01% | 3706 |
|
|
2025
Q1 | $3.13M | Buy |
2,143,110
+1,346,619
| +169% | +$1.97M | ﹤0.01% | 3360 |
|
|
2024
Q4 | $1.7M | Buy |
796,491
+449,151
| +129% | +$957K | ﹤0.01% | 3852 |
|
|
2024
Q3 | $973K | Buy |
347,340
+47,019
| +16% | +$132K | ﹤0.01% | 3614 |
|
|
2024
Q2 | $700K | Sell |
300,321
-218,880
| -42% | -$510K | ﹤0.01% | 3687 |
|
|
2024
Q1 | $2.32M | Buy |
519,201
+338,006
| +187% | +$1.51M | ﹤0.01% | 2850 |
|
|
2023
Q4 | $582K | Sell |
181,195
-25,564
| -12% | -$82.1K | ﹤0.01% | 3866 |
|
|
2023
Q3 | $655K | Sell |
206,759
-90,253
| -30% | -$286K | ﹤0.01% | 3418 |
|
|
2023
Q2 | $1.48M | Buy |
297,012
+64,501
| +28% | +$321K | ﹤0.01% | 2946 |
|
|
2023
Q1 | $1.15M | Buy |
232,511
+96,631
| +71% | +$477K | ﹤0.01% | 3073 |
|
|
2022
Q4 | $855K | Sell |
135,880
-45,596
| -25% | -$287K | ﹤0.01% | 3270 |
|
|
2022
Q3 | $1.96M | Buy |
181,476
+44,207
| +32% | +$477K | ﹤0.01% | 2372 |
|
|
2022
Q2 | $1.57M | Sell |
137,269
-85,598
| -38% | -$976K | ﹤0.01% | 2555 |
|
|
2022
Q1 | $2.03M | Buy |
222,867
+65,126
| +41% | +$593K | ﹤0.01% | 2639 |
|
|
2021
Q4 | $2.35M | Sell |
157,741
-14,769
| -9% | -$220K | ﹤0.01% | 2743 |
|
|
2021
Q3 | $4.43M | Buy |
172,510
+134,161
| +350% | +$3.45M | ﹤0.01% | 2111 |
|
|
2021
Q2 | $1M | Sell |
38,349
-47,409
| -55% | -$1.24M | ﹤0.01% | 3249 |
|
|
2021
Q1 | $3.03M | Buy |
85,758
+84,515
| +6,799% | +$2.98M | ﹤0.01% | 2402 |
|
|
2020
Q4 | $32K | Sell |
1,243
-199
| -14% | -$5.12K | ﹤0.01% | 5565 |
|
|
2020
Q3 | $54K | Sell |
1,442
-1,537
| -52% | -$57.6K | ﹤0.01% | 4741 |
|
|
2020
Q2 | $128K | Sell |
2,979
-174
| -6% | -$7.48K | ﹤0.01% | 4304 |
|
|
2020
Q1 | $62K | Buy |
3,153
+831
| +36% | +$16.3K | ﹤0.01% | 4772 |
|
|
2019
Q4 | $60K | Sell |
2,322
-1,605
| -41% | -$41.5K | ﹤0.01% | 5204 |
|
|
2019
Q3 | $107K | Sell |
3,927
-56,758
| -94% | -$1.55M | ﹤0.01% | 4813 |
|
|
2019
Q2 | $1.63M | Buy |
60,685
+51,427
| +555% | +$1.38M | ﹤0.01% | 2674 |
|
|
2019
Q1 | $268K | Buy |
9,258
+6,236
| +206% | +$181K | ﹤0.01% | 3688 |
|
|
2018
Q4 | $81K | Buy |
+3,022
| New | +$81K | ﹤0.01% | 4830 |
|